×
About 5,999 results

ALLMedicine™ IgA Nephropathy Center

Research & Reviews  2,955 results

Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With St...
https://doi.org/10.1016/j.clinthera.2021.03.009
Clinical Therapeutics; Zhao J, Ma F et. al.

Apr 17th, 2021 - This study assessed the long-term (10-year) tolerability and efficacy of a low-dose corticosteroid combined with mycophenolate mofetil (CS + MMF) in the treatment of immunoglobulin A nephropathy (IgAN) with stage 3/4 chronic kidney disease and pro...

Renal hemosiderosis presenting with acute kidney Injury and macroscopic hematuria in Im...
https://doi.org/10.1186/s12882-021-02334-w 10.1038/ki.1985.120 10.2215/CJN.02670706 10.1007/s13730-018-0325-2 10.1679/aohc.73.113 10.2215/CJN.01970211 10.1002/path.5011 10.1093/ndt/5.10.847 10.1038/ki.2011.470 10.1053/j.ajkd.2008.03.021 10.1182/blood.V57.1.83.83 10.1001/jama.2011.1141 10.2215/CJN.11521210
BMC Nephrology; Taguchi S, Hidaka S et. al.

Apr 16th, 2021 - Macroscopic hematuria-associated acute kidney injury (AKI) is a well-known complication of immunoglobulin A (IgA) nephropathy. In such cases, intratubular obstruction by red blood cell (RBC) casts and acute tubular necrosis are mainly observed pat...

How will artificial intelligence and bioinformatics change our understanding of IgA in ...
https://doi.org/10.1007/s00281-021-00847-y 10.1038/nrdp.2016.1 10.1007/s00467-017-3699-z 10.1007/s00281-013-0411-7 10.1038/nrneph.2015.208 10.1016/j.ekir.2020.08.009 10.1016/j.kint.2018.02.030 10.1007/s00467-017-3652-1 10.1093/ndt/gfaa223 10.1016/j.kint.2018.11.048 10.1038/s41581-020-0286-5 10.1038/s41581-019-0227-3 10.1159/000381738 10.1038/s41586-020-2941-1 10.1126/science.aat5031 10.1016/j.celrep.2020.108525 10.1080/14789450.2017.1331738 10.1038/s41598-017-09393-w 10.1038/nrneph.2017.30 10.1681/ASN.2012101006 10.1038/srep26138 10.1371/journal.pone.0099006 10.1002/mrc.4573 10.1007/s11306-012-0489-2 10.1042/CS20171107 10.1016/j.dld.2018.11.021 10.1007/s00248-015-0592-9 10.1038/s41598-020-73035-x 10.3389/fcimb.2020.557368 10.1016/j.intimp.2020.107085 10.1186/s12882-020-01741-9 10.1371/journal.pone.0081636 10.1016/S0272-6386(99)70141-1 10.1093/ndt/15.5.619 10.1111/j.1523-1755.2004.00714.x 10.1016/s0140-6736(94)90875-3 10.2353/ajpath.2010.090428 10.1172/JCI45563 10.1681/ASN.2015080911 10.1093/ndt/gfy323 10.1093/ndt/gfw343 10.1681/ASN.2016050496 10.1038/nbt1250 10.1073/pnas.0609643104 10.1021/nl103427w 10.1038/nmeth.2835 10.1016/j.cell.2018.07.010 10.1007/s00428-019-02705-7 10.1681/ASN.2015020204 10.1016/j.kint.2019.08.029 10.1038/nature14539 10.1038/s41591-018-0300-7 10.1038/s41591-019-0447-x 10.1016/S0140-6736(18)31645-3 10.1148/radiol.2017170700 10.1001/jama.2017.14585 10.1038/nature24270 10.1038/s41586-019-1724-z 10.1038/s41591-018-0213-5 10.1038/s41563-019-0345-0 10.1016/j.compbiomed.2017.09.014 10.1016/j.compmedimag.2018.11.002 10.1038/s41591-019-0703-0 10.1038/s41591-018-0316-z 10.1093/bib/bbx044 10.1038/s41576-019-0122-6 10.1016/j.kint.2020.02.027 10.1093/jamia/ocx030 10.1038/s41586-019-1390-1 10.1007/s00134-017-4678-3 10.1186/s13054-019-2563-x 10.1038/s41746-019-0100-6 10.1016/S2213-2600(18)30300-X 10.1111/ajt.15351 10.21037/atm.2020.01.09 10.1371/journal.pone.0228597 10.1016/j.kint.2020.02.028 10.1038/s41591-018-0177-5 10.1053/j.gastro.2020.06.021 10.1038/s41591-019-0462-y 10.1038/s41581-019-0220-x 10.1016/j.ajpath.2019.05.019 10.1016/j.ekir.2019.04.008 10.1681/ASN.2019020144 10.1038/ki.2012.428 10.1681/ASN.2018121259 10.1016/j.kint.2020.08.006 10.1093/ndt/13.1.67 10.1016/j.compbiomed.2015.09.003 10.1093/ndt/gfv232 10.1053/j.ajkd.2019.02.016 10.1016/j.ebiom.2020.102657 10.1001/jamanetworkopen.2020.0265 10.1007/s12553-017-0179-1 10.1145/3298981 10.1038/s41587-019-0214-z 10.1038/nrg.2016.69 10.1016/j.ekir.2020.07.012 10.1016/j.kint.2020.04.042 10.1038/s41551-020-0578-x 10.1073/pnas.1717139115 10.1016/j.kint.2020.04.046
Seminars in Immunopathology; Bülow RD, Dimitrov D et. al.

Apr 9th, 2021 - IgA nephropathy (IgAN) is the most common glomerulonephritis. It is characterized by the deposition of immune complexes containing immunoglobulin A (IgA) in the kidney's glomeruli, triggering an inflammatory process. In many patients, the disease ...

Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031432
PloS One; Mohd R, Mohammad Kazmin NE et. al.

Apr 8th, 2021 - IgA nephropathy (IgAN) has a heterogeneous presentation and the progression to end stage renal disease (ESRD) is often influenced by demographics, ethnicity, as well as choice of treatment regimen. In this study, we investigated the long term surv...

see more →

Guidelines  1 results

Evidence-based clinical practice guidelines for IgA nephropathy 2014.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956709
Clinical and Experimental Nephrology; Yuzawa Y, Yamamoto R et. al.

Apr 20th, 2016 - Evidence-based clinical practice guidelines for IgA nephropathy 2014.|2016|Yuzawa Y,Yamamoto R,Takahashi K,Katafuchi R,Tomita M,|diagnosis,etiology,therapy,

see more →

Clinicaltrials.gov  3,001 results

Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With St...
https://doi.org/10.1016/j.clinthera.2021.03.009
Clinical Therapeutics; Zhao J, Ma F et. al.

Apr 17th, 2021 - This study assessed the long-term (10-year) tolerability and efficacy of a low-dose corticosteroid combined with mycophenolate mofetil (CS + MMF) in the treatment of immunoglobulin A nephropathy (IgAN) with stage 3/4 chronic kidney disease and pro...

Renal hemosiderosis presenting with acute kidney Injury and macroscopic hematuria in Im...
https://doi.org/10.1186/s12882-021-02334-w 10.1038/ki.1985.120 10.2215/CJN.02670706 10.1007/s13730-018-0325-2 10.1679/aohc.73.113 10.2215/CJN.01970211 10.1002/path.5011 10.1093/ndt/5.10.847 10.1038/ki.2011.470 10.1053/j.ajkd.2008.03.021 10.1182/blood.V57.1.83.83 10.1001/jama.2011.1141 10.2215/CJN.11521210
BMC Nephrology; Taguchi S, Hidaka S et. al.

Apr 16th, 2021 - Macroscopic hematuria-associated acute kidney injury (AKI) is a well-known complication of immunoglobulin A (IgA) nephropathy. In such cases, intratubular obstruction by red blood cell (RBC) casts and acute tubular necrosis are mainly observed pat...

How will artificial intelligence and bioinformatics change our understanding of IgA in ...
https://doi.org/10.1007/s00281-021-00847-y 10.1038/nrdp.2016.1 10.1007/s00467-017-3699-z 10.1007/s00281-013-0411-7 10.1038/nrneph.2015.208 10.1016/j.ekir.2020.08.009 10.1016/j.kint.2018.02.030 10.1007/s00467-017-3652-1 10.1093/ndt/gfaa223 10.1016/j.kint.2018.11.048 10.1038/s41581-020-0286-5 10.1038/s41581-019-0227-3 10.1159/000381738 10.1038/s41586-020-2941-1 10.1126/science.aat5031 10.1016/j.celrep.2020.108525 10.1080/14789450.2017.1331738 10.1038/s41598-017-09393-w 10.1038/nrneph.2017.30 10.1681/ASN.2012101006 10.1038/srep26138 10.1371/journal.pone.0099006 10.1002/mrc.4573 10.1007/s11306-012-0489-2 10.1042/CS20171107 10.1016/j.dld.2018.11.021 10.1007/s00248-015-0592-9 10.1038/s41598-020-73035-x 10.3389/fcimb.2020.557368 10.1016/j.intimp.2020.107085 10.1186/s12882-020-01741-9 10.1371/journal.pone.0081636 10.1016/S0272-6386(99)70141-1 10.1093/ndt/15.5.619 10.1111/j.1523-1755.2004.00714.x 10.1016/s0140-6736(94)90875-3 10.2353/ajpath.2010.090428 10.1172/JCI45563 10.1681/ASN.2015080911 10.1093/ndt/gfy323 10.1093/ndt/gfw343 10.1681/ASN.2016050496 10.1038/nbt1250 10.1073/pnas.0609643104 10.1021/nl103427w 10.1038/nmeth.2835 10.1016/j.cell.2018.07.010 10.1007/s00428-019-02705-7 10.1681/ASN.2015020204 10.1016/j.kint.2019.08.029 10.1038/nature14539 10.1038/s41591-018-0300-7 10.1038/s41591-019-0447-x 10.1016/S0140-6736(18)31645-3 10.1148/radiol.2017170700 10.1001/jama.2017.14585 10.1038/nature24270 10.1038/s41586-019-1724-z 10.1038/s41591-018-0213-5 10.1038/s41563-019-0345-0 10.1016/j.compbiomed.2017.09.014 10.1016/j.compmedimag.2018.11.002 10.1038/s41591-019-0703-0 10.1038/s41591-018-0316-z 10.1093/bib/bbx044 10.1038/s41576-019-0122-6 10.1016/j.kint.2020.02.027 10.1093/jamia/ocx030 10.1038/s41586-019-1390-1 10.1007/s00134-017-4678-3 10.1186/s13054-019-2563-x 10.1038/s41746-019-0100-6 10.1016/S2213-2600(18)30300-X 10.1111/ajt.15351 10.21037/atm.2020.01.09 10.1371/journal.pone.0228597 10.1016/j.kint.2020.02.028 10.1038/s41591-018-0177-5 10.1053/j.gastro.2020.06.021 10.1038/s41591-019-0462-y 10.1038/s41581-019-0220-x 10.1016/j.ajpath.2019.05.019 10.1016/j.ekir.2019.04.008 10.1681/ASN.2019020144 10.1038/ki.2012.428 10.1681/ASN.2018121259 10.1016/j.kint.2020.08.006 10.1093/ndt/13.1.67 10.1016/j.compbiomed.2015.09.003 10.1093/ndt/gfv232 10.1053/j.ajkd.2019.02.016 10.1016/j.ebiom.2020.102657 10.1001/jamanetworkopen.2020.0265 10.1007/s12553-017-0179-1 10.1145/3298981 10.1038/s41587-019-0214-z 10.1038/nrg.2016.69 10.1016/j.ekir.2020.07.012 10.1016/j.kint.2020.04.042 10.1038/s41551-020-0578-x 10.1073/pnas.1717139115 10.1016/j.kint.2020.04.046
Seminars in Immunopathology; Bülow RD, Dimitrov D et. al.

Apr 9th, 2021 - IgA nephropathy (IgAN) is the most common glomerulonephritis. It is characterized by the deposition of immune complexes containing immunoglobulin A (IgA) in the kidney's glomeruli, triggering an inflammatory process. In many patients, the disease ...

Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031432
PloS One; Mohd R, Mohammad Kazmin NE et. al.

Apr 8th, 2021 - IgA nephropathy (IgAN) has a heterogeneous presentation and the progression to end stage renal disease (ESRD) is often influenced by demographics, ethnicity, as well as choice of treatment regimen. In this study, we investigated the long term surv...

see more →

News  31 results

HCV, HBV, and HIV associated with autoimmune kidney diseases
https://www.mdedge.com/fedprac/article/177898/hepatitis/hcv-hbv-and-hiv-associated-autoimmune-kidney-diseases
Mark S. Lesney

Oct 23rd, 2018 - Chronic viral infection can be associated with a variety of autoimmune kidney diseases, according to a review published in Rheumatic Disease Clinics. London_England/Thinkstock In particular, hepatitis C virus (HCV) infection can cause several kidn.

Steroids for IgA Nephropathy: Risks Outweigh Benefits in Some
https://www.medscape.com/viewarticle/883905

Aug 6th, 2017 - A high rate of serious adverse events led to the premature termination of a clinical trial designed to evaluate the efficacy of oral methylprednisolone in patients with immunoglobulin A (IgA) nephropathy despite evidence of a statistically signifi...

Steroids Linked to Serious Adverse Events in IgA Nephropathy
https://www.medpagetoday.com/nephrology/generalnephrology/66990

Aug 1st, 2017 - Action Points Corticosteroid treatment in patients with IgA nephropathy was tied to an increased risk for serious adverse events. Note that most adverse events occurred during the first 3 months of treatment, and they were primarily driven by an e...

STOP-IgAN Disappoints With No Benefit From Additional Rx
https://www.medscape.com/viewarticle/855965

Dec 14th, 2015 - The addition of an immunosuppressive regimen to ongoing comprehensive supportive care does not benefit patients with immunoglobulin A (IgA) nephropathy characterized by moderate proteinuria and chronic kidney disease stages 1 to 3, final results f...

A 20-Year-Old Man With a Dark, Burning Rash
https://reference.staging.medscape.com/viewarticle/849383_4

Aug 12th, 2015 - The patient meets the histopathologic criteria for solitary IgA nephropathy; the subsequent renal biopsy showed diffuse proliferative endocapillary glomerulonephritis with increased mesangial matrix and cellularity, capillary wall thickening, and ...

see more →

Patient Education  11 results see all →